• Sphingolipid metabolic enzymes modulate anticancer drug resistance 

    Min, Junxia (University of Missouri--Columbia, 2006)
    [ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] One of the most challenging aspects of cancer therapy today is the problem of drug resistance. The aim of our research is to understand the molecular ...